Skip to main content
PMC home page
Cancer Immunology, Immunotherapy : CII logoLink to Cancer Immunology, Immunotherapy : CII
. 1983 Dec;16(2):67–71. doi: 10.1007/BF00199233

Macrophages and antitumor reactions

W Den Otter 1, H F J Dullens 1,✉, R A De Weger 1
PMCID: PMC11039247  PMID: 6362848

The content is available as a PDF (559.0 KB).

References

  • 1.Adams DO, Johnson WJ, Marino PA. Mechanisms of target recognition and destruction in macrophage-mediated tumor cytotoxicity. Fed Proc. 1982;41:2212. [PubMed] [Google Scholar]
  • 2.Asano Y, Okumura J, Tada T. Ia antigens on antigen presenting cells do not carry the same Ia specificities as detected on suppressor and helper T-cells. Scand J Immunol. 1981;13:353. doi: 10.1111/j.1365-3083.1981.tb00144.x. [DOI] [PubMed] [Google Scholar]
  • 3.Askenase PW. Role of basophils, mast cells and vasoamines in hypersensitivity reactions with a delayed time course. Prog Allergy. 1977;23:199. [PubMed] [Google Scholar]
  • 4.Askenase PW, Burztajan S, Gershon MD, Gershon RK. T-cell-dependent mass cell degranulation and release of serotonin in murine delayed-type hypersensitivity. J Exp Med. 1980;152:1358. doi: 10.1084/jem.152.5.1358. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Beller DI, Unanue ER. Regulation of macrophage populations. II. Synthesis and expressing of Ia antigens by peritoneal exudate macrophages is a transient event. J Immunol. 1981;126:263. [PubMed] [Google Scholar]
  • 6.Beller DI, Farr AG, Unanue ER. Regulation of lymphocyte proliferation and differentiation by macrophages. Fed Proc. 1978;37:91. [PubMed] [Google Scholar]
  • 7.Conolly KM, Elgert KD. Concentration-dependent role of macrophages in mixed lymphocyte reaction regulation. Elaboration of non-dialyzable heat-labile soluble inhibitor and heat-labile enhancing factors. J Reticuloendothel Soc. 1979;25:243. [PubMed] [Google Scholar]
  • 8.Currie GA. Promotion of fibrosarcoma cell growth by products of syngeneic host macrophages. Br J Cancer. 1981;44:506. doi: 10.1038/bjc.1981.219. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Davies P, Allison AC. Secretion of macrophage enzymes in relation to the pathogenesis of chronic inflammation. In: Nelson DS, editor. Immunobiology of the macrophage. New York: Academic Press; 1976. p. 428. [Google Scholar]
  • 10.Davies P, Bonney RJ, Hanes JL, Kuechl FA. The synthesis of arachidonic acid oxidation products by various mononuclear phagocytes. In: van Furth R, editor. Mononuclear phagocytes: Functional aspects. The Hague: Martinus Nijhoff; 1980. p. 137. [Google Scholar]
  • 11.Denham S, Hooton JWL, Barfoot RK, Alexander P, Mayol R, Wrathmell AB. Mechanism by which antibodies to non-AgB antigens mediate rejection of rat leukaemia cells. Br J Cancer. 1980;42:408. doi: 10.1038/bjc.1980.252. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Den Otter W, Evans R, Alexander P. Cytotoxicity of murine peritoneal macrophages in tumor allograft immunity. Transplantation. 1972;14:220. doi: 10.1097/00007890-197208000-00012. [DOI] [PubMed] [Google Scholar]
  • 13.De Weger RA, Pels E, Den Otter W. The induction of lymphocytes with the capacity to render macrophages cytotoxic in an allogeneic murine system. Immunology. 1982;47:541. [PMC free article] [PubMed] [Google Scholar]
  • 14.Diamantstein T, Oppenheim JJ, Unanue ER, Wood DD, Handshumacher RE, Rosenstreich DL, Waksman BH. Non-specific lymphocyte activating factors produced by macrophages. Cell Immunol. 1979;46:422. doi: 10.1016/0008-8749(79)90430-1. [DOI] [PubMed] [Google Scholar]
  • 15.Dingemans KP, Pels E, Van Dongen G, Den Otter W. Destruction of murine lymphoma cells by allogeneic peritoneal macrophages in vitro: Influence of antiserum. JNCI. 1983;70:181. [PubMed] [Google Scholar]
  • 16.Dullens HFJ, Den Otter W. Therapy with allogeneic immune peritoneal cells. Cancer Res. 1974;341:1726. [PubMed] [Google Scholar]
  • 17.Dullens HFJ, Den Otter W. Murine macrophage cytotoxicity induced by mastocytoma cells, cell-free mastocytoma exudates, and extracts. Immunopharmacology. 1981;3:241. doi: 10.1016/0162-3109(81)90006-0. [DOI] [PubMed] [Google Scholar]
  • 18.Dullens HFJ, Den Otter W. A small-molecular-weight peptide from P815 mastocytoma cells induces macrophage cytotoxicity. Immunopharmacology. 1981;3:309. doi: 10.1016/0162-3109(81)90023-0. [DOI] [PubMed] [Google Scholar]
  • 19.Eccles SA, Alexander P. Macrophage content of tumors in relationship to metastatic spread. Nature. 1974;250:667. doi: 10.1038/250667a0. [DOI] [PubMed] [Google Scholar]
  • 20.Epstein L. Interferon as a model lymphokine. Fed Proc. 1981;40:56. [PubMed] [Google Scholar]
  • 21.Erb P, Feldman M. The role of macrophages in the generation of T-helper cells. I. Requirement for macrophages in helper cell induction and characteristics of the macrophage T-cell interaction. Cell Immunol. 1975;19:356. doi: 10.1016/0008-8749(75)90217-8. [DOI] [PubMed] [Google Scholar]
  • 22.Evans R. Macrophage requirement for growth of a murine fibrosarcoma. Br J Cancer. 1978;37:1086. doi: 10.1038/bjc.1978.158. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Evans R. Host cells in transplanted murine tumors and their possible relevance to tumor growth. J Reticuloendothel Soc. 1979;26:427. [PubMed] [Google Scholar]
  • 24.Evans R, Alexander P. Cooperation of immune lymphoid cells with macrophages in tumor immunity. Nature. 1970;228:620. doi: 10.1038/228620a0. [DOI] [PubMed] [Google Scholar]
  • 25.Evans R, Alexander P. Role of macrophages in tumour immunity. I. Cooperation between macrophages and lymphoid cells in syngeneic tumour immunity. Immunology. 1972;23:615. [PMC free article] [PubMed] [Google Scholar]
  • 26.Evans R, Lawler EM. Macrophage content and immunogenicity of C57BL/6J and BALB/c ByJ methylcholanthrene-induced sarcomas. Int J Cancer. 1980;26:831. doi: 10.1002/ijc.2910260618. [DOI] [PubMed] [Google Scholar]
  • 27.Farr AG, Kiely JM, Unanue ER. Macrophage T-cell interactions involving Listeria monocytogeneses — Role of the H-2 gene complex. J Immunol. 1979;122:2395. [PubMed] [Google Scholar]
  • 28.Farrar WL, Mizel SB, Farrar JJ. Participation of lymphocyte-activating factor (interleukin 1) in the induction of cytotoxic T-cell responses. J Immunol. 1980;124:1371. [PubMed] [Google Scholar]
  • 29.Fauve RM, Hevin B, Jacob H, Caillard JA, Jacob F. Anti-inflammatory effects of murine malignant cells. Proc Natl Acad Sci USA. 1974;71:4052. doi: 10.1073/pnas.71.10.4052. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Foster O, Landy M. Heterogeneity of mononuclear phagocytes. London: Academic Press; 1981. [Google Scholar]
  • 31.Friedman SA, Remold-O'Donnel E, Piessens WF. Enhanced PGE production by MAF-treated peritoneal exudate macrophages. Cell Immunol. 1978;42:213. doi: 10.1016/0008-8749(79)90237-5. [DOI] [PubMed] [Google Scholar]
  • 32.Gemsa D, Kramer W, Napierski I, Bärlin E, Till G, Riesch K. Potentiation of macrophage tumor cytostasis by tumor-induced ascites. J Immunol. 1981;126:2143. [PubMed] [Google Scholar]
  • 33.Giovarelli M, Comoglio PM, Forni G. Induction of resistance or enhancement to a transplantable murine plasmacytoma by transfer of non-immune leukocytes. Br J Cancer. 1976;34:233. doi: 10.1038/bjc.1976.157. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Glaser M. Indomethacin-sensitive suppressor cells regulate the cell-mediated response to SV-40-induced associated antigens in mice. Eur J Immunol. 1980;10:489. doi: 10.1002/eji.1830100702. [DOI] [PubMed] [Google Scholar]
  • 35.Han T, Takita H. Indomethacin-mediated enhancement of lymphocyte response to mitogens in healthy subjects and lung cancer patients. Cancer. 1980;46:2416. doi: 10.1002/1097-0142(19801201)46:11<2416::aid-cncr2820461120>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
  • 36.Haskill JS. Tumor immunity in prognosis: The role of mononuclear cell infiltration. New York: Dekker; 1982. [Google Scholar]
  • 37.Haskill JS, Fett JW. Possible evidence for antibody-dependent macrophage-mediated cytotoxicity directed against murine adenocarcinoma cells in vivo. J Immunol. 1976;117:1992. [PubMed] [Google Scholar]
  • 38.Haskill JS, Parthenais E. Immunologic factors influencing the intra-tumor localization of ADCC effector cells. J Immunol. 1978;120:1813. [PubMed] [Google Scholar]
  • 39.Herberman RB, Holden HT, Djeu JY, Jerrels TR, Varesio L, Tagliabue A, White SL, Dehler JR, Dean JH. Macrophages as regulators of the immune responses against tumors. In: Estobar MR, Friedman H, editors. Macrophages and lymphocytes, part B. New York: Plenum Press; 1979. p. 361. [DOI] [PubMed] [Google Scholar]
  • 40.Herberman RB, Holden HT, Djeu JY, Jerrels TR, Varesio L, Tagliabue A, White SL, Oehler JR, Dean JH. Macrophages as regulators of immune responses against tumors. Adv Exp Med Biol. 1980;121b:361. doi: 10.1007/978-1-4684-8914-9_35. [DOI] [PubMed] [Google Scholar]
  • 41.Herlyn D, Koprowski H. Ig2a monoclonal antibodies inhibit tumor growth through interaction with effector cells. Proc Natl Acad Sci USA. 1982;79:4761. doi: 10.1073/pnas.79.15.4761. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Hibbs JB. The macrophages as tumoricidal effector cells: A review of in vivo and in vitro studies on the mechanism of the activated macrophages nonspecific cytotoxic reaction. In: Fink MA, editor. The macrophages in neoplasia. New York: Academic Press; 1976. p. 83. [Google Scholar]
  • 43.Huget RP, Flad HD, Opitz HG. Promotion of L1210 tumor growth by macrophages. Z Immunol Forsch. 1978;154:433. [PubMed] [Google Scholar]
  • 44.Johnson RT, Siliciano RF, Shin HS. Suppression of antibody-sensitized tumor cells by macrophages: Insufficient supply or activation of macrophages within large tumors. J Immunol. 1979;122:379. [PubMed] [Google Scholar]
  • 45.Kaplan J. Polypeptide binding membrane receptors: analysis and classification. Science. 1981;212:14. doi: 10.1126/science.6259730. [DOI] [PubMed] [Google Scholar]
  • 46.Lee KC. On the origin and mode of action of functionally distinct macrophage subpopulations. Mol Cell Biochem. 1980;30:39. doi: 10.1007/BF00215304. [DOI] [PubMed] [Google Scholar]
  • 47.Lee KC, Wilkinson A, Wong M. Antigen-specific murine T-cell proliferation: role of macrophages surface Ia and factors. Cell Immunol. 1979;48:79. doi: 10.1016/0008-8749(79)90101-1. [DOI] [PubMed] [Google Scholar]
  • 48.Lee KC, Wong M, McIntyre D. Characterization of macrophage subpopulations response to activation by endotoxin and lymphokines. J Immunol. 1981;126:2474. [PubMed] [Google Scholar]
  • 49.Mantovani A. Effects on in vitro tumor growth of murine macrophages isolated from sarcoma lines differing in immunogeneity and metastasing capacity. Int J Cancer. 1978;22:741. doi: 10.1002/ijc.2910220617. [DOI] [PubMed] [Google Scholar]
  • 50.Meltzer MS, Occhionero M, Ruco LP. Macrophage activation for tumor cytotoxicity: Regulation mechanisms for induction and control of cytotoxic activity. Fed Proc. 1982;41:2198. [PubMed] [Google Scholar]
  • 51.Mottram PL, Miller JFAP. Delayed hypersensitivity induced by antigen pulsed bone marrow derived macrophages. Eur J Immunol. 1980;10:165. doi: 10.1002/eji.1830100302. [DOI] [PubMed] [Google Scholar]
  • 52.Mottram PL, Potter TA, McKenzie IFC, Miller JFAP. Serological analysis of macrophage surface alloantigens. Cell Immunol. 1981;59:151. doi: 10.1016/0008-8749(81)90442-1. [DOI] [PubMed] [Google Scholar]
  • 53.Mizel SB. Studies on the purification and structure-function relationships of murine lymphocyte-activating factor (interleukin 1) Mol Immunol. 1980;17:571. doi: 10.1016/0161-5890(80)90155-8. [DOI] [PubMed] [Google Scholar]
  • 54.Nathan CF, Murray HW, Cohn ZA. The macrophage as an effector cell. N Engl J Med. 1980;303:622. doi: 10.1056/NEJM198009113031106. [DOI] [PubMed] [Google Scholar]
  • 55.Pels E, Den Otter W. A cytophilic factor from challenged immune lymphocytes in specific macrophage cytotoxicity. Cancer Res. 1974;34:3089. [PubMed] [Google Scholar]
  • 56.Pels E, Den Otter W. Natural cytotoxic macrophages in the peritoneal cavity of mice. Br J Cancer. 1979;40:856. doi: 10.1038/bjc.1979.276. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Pennline KJ, Herscowitz HB. Dual role alveolar macrophages in humoral and cell-mediated immune responses: Evidence for suppressor and enhancing functions. J Reticuloendothel Soc. 1981;30:205. [PubMed] [Google Scholar]
  • 58.Piguet PF, Vassali P. Immunosuppressor cells from newborn mouse spleen are macrophages differentiating in vitro from monoblastic precursors. Eur J Immunol. 1981;11:56. doi: 10.1002/eji.1830110112. [DOI] [PubMed] [Google Scholar]
  • 59.Ptak W, Zembala M, Asherson GL, Marcinkiewicz J. Inhibition of contact sensitivity by macrophages. The separate phenomena of the production of non-specific macrophage factor by macrophages armed with specific T-suppressor factor and the nonspecific inhibition of passive transfer by high density of macrophages. Int Arch Allergy Appl Immunol. 1981;65:121. doi: 10.1159/000232747. [DOI] [PubMed] [Google Scholar]
  • 60.Ralph P, Williams N, Nakoinz I, Jackson H, Watson JD. Distinct signals for antibody-dependent and non-specific killing of tumor targets mediated by macrophages. J Immunol. 1982;129:427. [PubMed] [Google Scholar]
  • 61.Reynolds CW, Brunda MJ, Holden HT, Herberman RB. Role of macrophages in in vitro augmentation of rat, mouse and human natural killer activities. J Natl Cancer Inst. 1981;66:837. [PubMed] [Google Scholar]
  • 62.Rhodes J. Resistance of tumor cells to macrophages. A short review. Cancer Immunol Immunother. 1980;7:211. [Google Scholar]
  • 63.Rosenwasser LJ, Rosenthal AS. Adherent cell function in murine T-lymphocyte recognition. I. A macrophage-dependent T-cell proliferation assay in the mouse. J Immunol. 1978;120:1991. [PubMed] [Google Scholar]
  • 64.Ruco LP, Meltzer MS. Macrophage activation for tumor cytotoxicity: Increased lymphokine responsiveness of peritoneal macrophages during acute inflammation. J Immunol. 1978;120:1054. [PubMed] [Google Scholar]
  • 65.Russell SW, Gillespie YG, Pace JC. Evidence for mononuclear phagocytes in solid neoplasms and appraisal of their non-specific cytotoxic capabilities. Contemp Top Immunobiol. 1980;10:143. doi: 10.1007/978-1-4684-3677-8_6. [DOI] [PubMed] [Google Scholar]
  • 66.Schroit AJ, Fidler IJ. Effects of liposome structure and lipid composition on the activation of the tumoricidal properties of macrophages by liposomes containing muramyl-dipeptide. Cancer Res. 1982;42:161. [PubMed] [Google Scholar]
  • 67.Smith F, Miller JFAP. Delayed-type hypersensitivity to allogeneic cells in mice. III. Sensitivity to cell surface antigens coded by the major histocompatibility complex and by other genes. J Exp Med. 1979;150:965. doi: 10.1084/jem.150.4.965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Snyderman R, Pike MG, Blaylock BL, Weinstein P. Effects of neoplasms on inflammation: depression of macrophage accumulation after tumor implantation. J Immunol. 1976;116:585. [PubMed] [Google Scholar]
  • 69.Sorg C, Neuman C. A developmental concept for the heterogeneity of macrophages in response to lymphokines and other signals. In: Pick E, Landy M, editors. Lymphokines, vol 3. New York: Academic Press; 1982. p. 85. [Google Scholar]
  • 70.Taffet SM, Russel SW. Macrophage-mediated tumor cell killing: Regulation of expression of cytolytic activity by prostaglandin E. Eur J Immunol. 1981;126:424. [PubMed] [Google Scholar]
  • 71.Talmadge JE, Key M, Fidler IJ. Macrophage content of metastatic and non-metastatic rodent neoplasms. J Immunol. 1981;126:2245. [PubMed] [Google Scholar]
  • 72.Thorbecke GJ, Silberberg-Sinakin I, Flotte TJ. Langerhans cells as macrophages in skin and lymphoid organs. J Invest Dermatol. 1980;75:32. doi: 10.1111/1523-1747.ep12521083. [DOI] [PubMed] [Google Scholar]
  • 73.Tzechoval E, Baetserlier P, Feldman M, Segal S. The peritoneal antigen presenting macrophage: control and immunogenic properties of distinct subpopulations. Eur J Immunol. 1981;11:323. doi: 10.1002/eji.1830110411. [DOI] [PubMed] [Google Scholar]
  • 74.Van Loveren H, Den Otter W. In vitro activation of armed macrophages and the therapeutic application in mice. J Natl Cancer Inst. 1974;52:1917. doi: 10.1093/jnci/52.6.1917. [DOI] [PubMed] [Google Scholar]
  • 75.Van Loveren H, Snoek M, Den Otter W. Effects of silica on macrophages and lymphocytes. J Reticuloendothelial Soc. 1977;22:523. [PubMed] [Google Scholar]
  • 76.Van Loveren H, De Groot JW, Den Otter W. Macrophage tumor cells can help to cure murine lymphoma. Proc Soc Exp Biol Med. 1981;167:207. doi: 10.3181/00379727-167-41150. [DOI] [PubMed] [Google Scholar]
  • 77.Van Loveren H, Snoek M, Den Otter W. Host macrophages are involved in systemic adoptive immunity against tumors. Experientia. 1982;38:488. doi: 10.1007/BF01952654. [DOI] [PubMed] [Google Scholar]
  • 78.Varesio L, Herberman RB, Gershon JM, Holden HT. Suppression of lymphokine production by macrophages infiltrating murine virus induced tumors. Int J Cancer. 1979;24:97. doi: 10.1002/ijc.2910240117. [DOI] [PubMed] [Google Scholar]
  • 79.Webbs PJ, Brooks GG, Baldwin RW. Macrophage-like suppressor cells in rats. II. Evidence for a quantitative rather than a qualitative change in tumor bearer animals. Cell Immunol. 1980;52:381. doi: 10.1016/0008-8749(80)90359-7. [DOI] [PubMed] [Google Scholar]
  • 80.Youdim S. Enhancing and suppressive effects of macrophages on T-lymphocyte stimulation in vitro. Cell Immunol. 1979;45:377. doi: 10.1016/0008-8749(79)90398-8. [DOI] [PubMed] [Google Scholar]

Articles from Cancer Immunology, Immunotherapy : CII are provided here courtesy of Springer

RESOURCES